Black Rock Inc. Gritstone Bio, Inc. Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GRTS
# of Institutions
20Shares Held
17.8MCall Options Held
68.3KPut Options Held
59.8K-
Israel Englander Millennium Management LLC | New York, Ny1.14MShares$34,2150.0% of portfolio
-
Jane Street Group, LLC New York, NY138KShares$4,1450.0% of portfolio
-
Telemetry Investments, L.L.C. New York, NY105KShares$3,1500.57% of portfolio
-
Point72 Asia (Singapore) Pte. Ltd. Singapore, U075.4KShares$2,2630.01% of portfolio
-
Baader Bank Aktiengesellschaft Unterschleissheim, 2M67.1KShares$2,0140.0% of portfolio
About Gritstone bio, Inc.
- Ticker GRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,006,896
- Market Cap $2.19M
- Description
- Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...